Bulletin
Investor Alert

Cyclerion Therapeutics Inc.

NAS: CYCN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 25, 2022, 4:47 p.m.

/zigman2/quotes/207301221/composite

$

1.25

Change

+0.01 +0.81%

Volume

Volume 101

Quotes are delayed by 20 min

/zigman2/quotes/207301221/composite

Today's close

$ 1.30

$ 1.24

Change

-0.06 -4.62%

Day low

Day high

$1.17

$1.29

Open

52 week low

52 week high

$1.13

$6.90

Open

Annual Financials for Cyclerion Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue ---4.51M2.3M
Cost of Goods Sold (COGS) incl. D&A 2.17M1.75M1.53M--
COGS excluding D&A -----
Depreciation & Amortization Expense 2.17M1.75M1.53M2.7M2.3M
Depreciation 2.17M1.75M1.53M2.7M2.3M
Amortization of Intangibles -----
Gross Income (2.17M)(1.75M)(1.53M)--
20162017201820192020 5-year trend
SG&A Expense 61.38M92.18M113.72M121.91M77.03M
Research & Development 50.9M78.8M87.72M95.14M56.41M
Other SG&A 10.48M13.37M26.01M26.77M20.62M
Other Operating Expense -----
Unusual Expense ---4.19M1.2M
EBIT after Unusual Expense ---(124.29M)(78.23M)
Non Operating Income/Expense ---(751,000)429,000
Non-Operating Interest Income ---2.03M-
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (63.55M)(93.92M)(115.25M)(123.01M)(77.8M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (63.55M)(93.92M)(115.25M)(123.01M)(77.8M)
Minority Interest Expense -----
Net Income (63.55M)(93.92M)(115.25M)(123.01M)(77.8M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (63.55M)(93.92M)(115.25M)(123.01M)(77.8M)
Preferred Dividends -----
Net Income Available to Common (63.55M)(93.92M)(115.25M)(123.01M)(77.8M)
EPS (Basic) (2.32)(3.43)(4.21)(4.49)(2.56)
Basic Shares Outstanding 27.4M27.4M27.4M27.38M30.4M
EPS (Diluted) (2.32)(3.43)(4.21)(4.49)(2.56)
Diluted Shares Outstanding 27.4M27.4M27.4M27.38M30.4M
EBITDA (61.38M)(92.18M)(113.72M)(117.4M)(74.74M)
Trending Tickers
  • /zigman2/quotes/207505872/composite DISH+1.05%
  • /zigman2/quotes/204151124/composite CURE-1.23%
  • /zigman2/quotes/214908404/composite GFL+1.15%
  • /zigman2/quotes/204236046/composite DUST+1.32%
  • /zigman2/quotes/200683073/composite FRC+0.90%
X
Powered by StockTwits
Link to MarketWatch's Slice.